Scientists studying the remarkable regenerative capabilities of axolotls, zebrafish, and mice have identified a common genetic pathway that could pave…
Read More
Kardigan Aims for Nasdaq Listing to Fuel Clinical Advancement of Key Cardiology Therapies
Kardigan, a biopharmaceutical company focused on innovative cardiovascular treatments, is strategically pursuing an Initial Public Offering (IPO) on the Nasdaq…
Read More
Pharma R&D Returns Soar to 7% Driven Almost Exclusively by GLP-1 Therapies, Deloitte Report Reveals
The pharmaceutical industry, after a period characterized by uneven growth and post-pandemic recalibration, is witnessing a significant upturn in R&D…
Read More
Molecular Switch Discovery in Blood Stem Cells Offers New Potential for Bone Marrow Transplants and Gene Therapies
A team of investigators at Weill Cornell Medicine has identified a singular molecular switch that is fundamental to the activation…
Read More
Regeneron Pharmaceuticals and Parabilis Medicines Forge Landmark $2.32 Billion Collaboration to Pioneer a New Era of Intracellular Therapies
Regeneron Pharmaceuticals has announced a monumental research collaboration with Parabilis Medicines, a deal valued at an impressive $2.32 billion. This…
Read More
Researchers Uncover Dual-Ligase Mechanism for Targeted Protein Degradation, Paving Way for More Robust and Durable Cancer Therapies
A groundbreaking study has identified a novel mechanism by which a single small molecule can leverage two distinct cellular pathways…
Read More
Breakthrough Discovery by McGill Researchers Identifies Cellular Disruptions in the Depressed Brain Paving the Way for Targeted Therapies
In a landmark study that bridges the gap between molecular genetics and clinical psychiatry, researchers at McGill University and the…
Read More
Sai Life Sciences Hosts Landmark Biotech Pitch Day 2026, Spotlighting Innovative Early-Stage Therapies and Fostering Strategic Collaborations
Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
The Dawn of In Vivo Cell Therapies: A New Era in Precision Medicine Unfolds Amidst Significant Investment and Innovation
The pharmaceutical landscape is witnessing a profound transformation with the ascendance of in vivo cell therapies, a revolutionary approach that…
Read More
US Food and Drug Administration Unveils Draft Guidance for Genome Editing Therapies, Prioritizing Safety Through Next-Generation Sequencing
The US Food and Drug Administration (FDA) has issued draft guidance aimed at enhancing the safety assessment of genome editing…
Read More
